Back
BlackRock Vs. Akero Therapeutics Industry Stock Comparison
Buy
64
BLK
BlackRock
Last Price:
$991.04
Seasonality Move:
4.04%
Buy
68
AKRO
Akero Therapeutics
Last Price:
$53.57
Seasonality Move:
26.74%
Buy
68
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.28. The Score for AKRO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
BLK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 14.85 | Buy |
Relative Strength Index (14 RSI): | 61.48 | Buy |
Chaikin Money Flow: | -469126 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (939.27 - 990.65) | Buy |
Bollinger Bands (100): | (904.69 - 1005.87) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.09 | Buy |
Relative Strength Index (14 RSI): | 70.44 | Buy |
Chaikin Money Flow: | -1219058 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.53 - 50.43) | Buy |
Bollinger Bands (100): | (34.89 - 51.35) | Buy |
BLK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 981.4 | Buy |
20-day SMA: | 975.51 | Buy |
50-day SMA: | 930.23 | Buy |
200-day SMA: | 967.53 | Buy |
8-day EMA: | 982.78 | Buy |
20-day EMA: | 970.27 | Buy |
50-day EMA: | 953.07 | Buy |
200-day EMA: | 938.3 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.82 | Buy |
20-day SMA: | 46 | Buy |
50-day SMA: | 42.47 | Buy |
200-day SMA: | 36.08 | Buy |
8-day EMA: | 51.3 | Buy |
20-day EMA: | 47.76 | Buy |
50-day EMA: | 44.57 | Buy |
200-day EMA: | 37.75 | Buy |
BlackRock Earnings Growth & BLK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.54 per share, an increase next quarter of $0.82 per share, an increase this year of $2.16 per share, and an increase next year of $5.23 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
BlackRock Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |